Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the better-wp-security domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home1/thepumlw/public_html/wp-includes/functions.php on line 6114
Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home1/thepumlw/public_html/wp-includes/functions.php on line 6114
Warning: Cannot modify header information - headers already sent by (output started at /home1/thepumlw/public_html/wp-includes/functions.php:6114) in /home1/thepumlw/public_html/wp-includes/rest-api/class-wp-rest-server.php on line 1893
Warning: Cannot modify header information - headers already sent by (output started at /home1/thepumlw/public_html/wp-includes/functions.php:6114) in /home1/thepumlw/public_html/wp-includes/rest-api/class-wp-rest-server.php on line 1893
Warning: Cannot modify header information - headers already sent by (output started at /home1/thepumlw/public_html/wp-includes/functions.php:6114) in /home1/thepumlw/public_html/wp-includes/rest-api/class-wp-rest-server.php on line 1893
Warning: Cannot modify header information - headers already sent by (output started at /home1/thepumlw/public_html/wp-includes/functions.php:6114) in /home1/thepumlw/public_html/wp-includes/rest-api/class-wp-rest-server.php on line 1893
Warning: Cannot modify header information - headers already sent by (output started at /home1/thepumlw/public_html/wp-includes/functions.php:6114) in /home1/thepumlw/public_html/wp-includes/rest-api/class-wp-rest-server.php on line 1893
Warning: Cannot modify header information - headers already sent by (output started at /home1/thepumlw/public_html/wp-includes/functions.php:6114) in /home1/thepumlw/public_html/wp-includes/rest-api/class-wp-rest-server.php on line 1893
Warning: Cannot modify header information - headers already sent by (output started at /home1/thepumlw/public_html/wp-includes/functions.php:6114) in /home1/thepumlw/public_html/wp-includes/rest-api/class-wp-rest-server.php on line 1893
Warning: Cannot modify header information - headers already sent by (output started at /home1/thepumlw/public_html/wp-includes/functions.php:6114) in /home1/thepumlw/public_html/wp-includes/rest-api/class-wp-rest-server.php on line 1893
{"id":46951,"date":"2024-02-03T08:28:07","date_gmt":"2024-02-03T08:28:07","guid":{"rendered":"https:\/\/thepurbottar.in\/?p=46951"},"modified":"2024-02-03T08:28:09","modified_gmt":"2024-02-03T08:28:09","slug":"glenmark-and-pfizer-partners-to-launch-abrocitinib-in-india","status":"publish","type":"post","link":"https:\/\/thepurbottar.in\/glenmark-and-pfizer-partners-to-launch-abrocitinib-in-india\/","title":{"rendered":"Glenmark and Pfizer partners to launch Abrocitinib in India"},"content":{"rendered":"\nPfizer and Glenmark Pharmaceuticals Ltd. have partnered to launch abrocitinib, a unique oral advanced systemic treatment for moderate-to-severe atopic dermatitis in India. Developed by Pfizer, abrocitinib has received marketing authorization from the Central Drugs Standard Control Organization (CDSCO) in India and is approved by the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and other regulatory agencies.<\/p>\n\n\n\n
When launched in India, it will be co-marketed under the brand names JABRYUS\u00ae and CIBINQO\u00ae by Glenmark and Pfizer respectively. This collaboration combines the expertise of the companies to offer a groundbreaking treatment for moderate-to-severe AD, with improved efficacy and oral convenience to patients. Meenakshi Nevatia, Country President and Managing Director of Pfizer India stated, “Our collaboration with Glenmark will help leverage the collective strengths and capabilities of our organizations to make this breakthrough therapy available to patients and physicians across our country.\u201d<\/p>\n\n\n\n
Atopic dermatitis is a chronic skin disease causing inflammation and skin barrier defects. Itching in moderate-to-severe AD disrupts daily life, impacting social interactions, work productivity, and overall well-being. Abrocitinib, a Janus kinase 1 inhibitor, provides rapid itch relief, sustained disease control, and improved quality of life.<\/p>\n","protected":false},"excerpt":{"rendered":"
Pfizer and Glenmark Pharmaceuticals Ltd. have partnered to launch abrocitinib, a unique oral advanced systemic treatment for moderate-to-severe atopic dermatitis in India. Developed by Pfizer, abrocitinib has received marketing authorization from the Central Drugs Standard Control Organization (CDSCO) in India and is approved by the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), […]<\/p>\n","protected":false},"author":22,"featured_media":46952,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"sb_editor_width":"","footnotes":""},"categories":[7],"tags":[],"class_list":["post-46951","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business"],"relative_dates":{"created":"10 months ago","modified":"10 months ago"},"yoast_head":"\n
Glenmark and Pfizer partners to launch Abrocitinib in India - The Purbottar<\/title>\n<meta name=\"description\" content=\"Pfizer and Glenmark Pharmaceuticals Ltd. have partnered to launch abrocitinib, a unique oral advanced systemic treatment for moderate-to-severe atopic\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/thepurbottar.in\/glenmark-and-pfizer-partners-to-launch-abrocitinib-in-india\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Glenmark and Pfizer partners to launch Abrocitinib in India - The Purbottar\" \/>\n<meta property=\"og:description\" content=\"Pfizer and Glenmark Pharmaceuticals Ltd. have partnered to launch abrocitinib, a unique oral advanced systemic treatment for moderate-to-severe atopic\" \/>\n<meta property=\"og:url\" content=\"https:\/\/thepurbottar.in\/glenmark-and-pfizer-partners-to-launch-abrocitinib-in-india\/\" \/>\n<meta property=\"og:site_name\" content=\"The Purbottar\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/purbottarnewsportal\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-03T08:28:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-02-03T08:28:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/thepurbottar.in\/wp-content\/uploads\/2024\/02\/Glenmark.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"776\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Business Bureau\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Bureau\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/thepurbottar.in\/glenmark-and-pfizer-partners-to-launch-abrocitinib-in-india\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/thepurbottar.in\/glenmark-and-pfizer-partners-to-launch-abrocitinib-in-india\/\"},\"author\":{\"name\":\"Business Bureau\",\"@id\":\"https:\/\/thepurbottar.in\/#\/schema\/person\/e6e81f9f5be6eff095fcc2a50437bfc6\"},\"headline\":\"Glenmark and Pfizer partners to launch Abrocitinib in India\",\"datePublished\":\"2024-02-03T08:28:07+00:00\",\"dateModified\":\"2024-02-03T08:28:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/thepurbottar.in\/glenmark-and-pfizer-partners-to-launch-abrocitinib-in-india\/\"},\"wordCount\":197,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/thepurbottar.in\/#organization\"},\"image\":{\"@id\":\"https:\/\/thepurbottar.in\/glenmark-and-pfizer-partners-to-launch-abrocitinib-in-india\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/thepurbottar.in\/wp-content\/uploads\/2024\/02\/Glenmark.jpg\",\"articleSection\":[\"Business\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/thepurbottar.in\/glenmark-and-pfizer-partners-to-launch-abrocitinib-in-india\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/thepurbottar.in\/glenmark-and-pfizer-partners-to-launch-abrocitinib-in-india\/\",\"url\":\"https:\/\/thepurbottar.in\/glenmark-and-pfizer-partners-to-launch-abrocitinib-in-india\/\",\"name\":\"Glenmark and Pfizer partners to launch Abrocitinib in India - The Purbottar\",\"isPartOf\":{\"@id\":\"https:\/\/thepurbottar.in\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/thepurbottar.in\/glenmark-and-pfizer-partners-to-launch-abrocitinib-in-india\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/thepurbottar.in\/glenmark-and-pfizer-partners-to-launch-abrocitinib-in-india\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/thepurbottar.in\/wp-content\/uploads\/2024\/02\/Glenmark.jpg\",\"datePublished\":\"2024-02-03T08:28:07+00:00\",\"dateModified\":\"2024-02-03T08:28:09+00:00\",\"description\":\"Pfizer and Glenmark Pharmaceuticals Ltd. have partnered to launch abrocitinib, a unique oral advanced systemic treatment for moderate-to-severe atopic\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/thepurbottar.in\/glenmark-and-pfizer-partners-to-launch-abrocitinib-in-india\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thepurbottar.in\/glenmark-and-pfizer-partners-to-launch-abrocitinib-in-india\/#primaryimage\",\"url\":\"https:\/\/thepurbottar.in\/wp-content\/uploads\/2024\/02\/Glenmark.jpg\",\"contentUrl\":\"https:\/\/thepurbottar.in\/wp-content\/uploads\/2024\/02\/Glenmark.jpg\",\"width\":1200,\"height\":776},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/thepurbottar.in\/#website\",\"url\":\"https:\/\/thepurbottar.in\/\",\"name\":\"The Purbottar\",\"description\":\"English News Paper\",\"publisher\":{\"@id\":\"https:\/\/thepurbottar.in\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/thepurbottar.in\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/thepurbottar.in\/#organization\",\"name\":\"The Purbottar\",\"url\":\"https:\/\/thepurbottar.in\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thepurbottar.in\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/i0.wp.com\/thepurbottar.in\/wp-content\/uploads\/2023\/08\/purbottar-english-logo-544px.png?fit=544%2C180&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/thepurbottar.in\/wp-content\/uploads\/2023\/08\/purbottar-english-logo-544px.png?fit=544%2C180&ssl=1\",\"width\":544,\"height\":180,\"caption\":\"The Purbottar\"},\"image\":{\"@id\":\"https:\/\/thepurbottar.in\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/purbottarnewsportal\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/thepurbottar.in\/#\/schema\/person\/e6e81f9f5be6eff095fcc2a50437bfc6\",\"name\":\"Business Bureau\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thepurbottar.in\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a3c076ea9e207c179b27b41ba41c073f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a3c076ea9e207c179b27b41ba41c073f?s=96&d=mm&r=g\",\"caption\":\"Business Bureau\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Glenmark and Pfizer partners to launch Abrocitinib in India - The Purbottar","description":"Pfizer and Glenmark Pharmaceuticals Ltd. have partnered to launch abrocitinib, a unique oral advanced systemic treatment for moderate-to-severe atopic","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/thepurbottar.in\/glenmark-and-pfizer-partners-to-launch-abrocitinib-in-india\/","og_locale":"en_US","og_type":"article","og_title":"Glenmark and Pfizer partners to launch Abrocitinib in India - The Purbottar","og_description":"Pfizer and Glenmark Pharmaceuticals Ltd. have partnered to launch abrocitinib, a unique oral advanced systemic treatment for moderate-to-severe atopic","og_url":"https:\/\/thepurbottar.in\/glenmark-and-pfizer-partners-to-launch-abrocitinib-in-india\/","og_site_name":"The Purbottar","article_publisher":"https:\/\/www.facebook.com\/purbottarnewsportal\/","article_published_time":"2024-02-03T08:28:07+00:00","article_modified_time":"2024-02-03T08:28:09+00:00","og_image":[{"width":1200,"height":776,"url":"https:\/\/thepurbottar.in\/wp-content\/uploads\/2024\/02\/Glenmark.jpg","type":"image\/jpeg"}],"author":"Business Bureau","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Bureau","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/thepurbottar.in\/glenmark-and-pfizer-partners-to-launch-abrocitinib-in-india\/#article","isPartOf":{"@id":"https:\/\/thepurbottar.in\/glenmark-and-pfizer-partners-to-launch-abrocitinib-in-india\/"},"author":{"name":"Business Bureau","@id":"https:\/\/thepurbottar.in\/#\/schema\/person\/e6e81f9f5be6eff095fcc2a50437bfc6"},"headline":"Glenmark and Pfizer partners to launch Abrocitinib in India","datePublished":"2024-02-03T08:28:07+00:00","dateModified":"2024-02-03T08:28:09+00:00","mainEntityOfPage":{"@id":"https:\/\/thepurbottar.in\/glenmark-and-pfizer-partners-to-launch-abrocitinib-in-india\/"},"wordCount":197,"commentCount":0,"publisher":{"@id":"https:\/\/thepurbottar.in\/#organization"},"image":{"@id":"https:\/\/thepurbottar.in\/glenmark-and-pfizer-partners-to-launch-abrocitinib-in-india\/#primaryimage"},"thumbnailUrl":"https:\/\/thepurbottar.in\/wp-content\/uploads\/2024\/02\/Glenmark.jpg","articleSection":["Business"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/thepurbottar.in\/glenmark-and-pfizer-partners-to-launch-abrocitinib-in-india\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/thepurbottar.in\/glenmark-and-pfizer-partners-to-launch-abrocitinib-in-india\/","url":"https:\/\/thepurbottar.in\/glenmark-and-pfizer-partners-to-launch-abrocitinib-in-india\/","name":"Glenmark and Pfizer partners to launch Abrocitinib in India - The Purbottar","isPartOf":{"@id":"https:\/\/thepurbottar.in\/#website"},"primaryImageOfPage":{"@id":"https:\/\/thepurbottar.in\/glenmark-and-pfizer-partners-to-launch-abrocitinib-in-india\/#primaryimage"},"image":{"@id":"https:\/\/thepurbottar.in\/glenmark-and-pfizer-partners-to-launch-abrocitinib-in-india\/#primaryimage"},"thumbnailUrl":"https:\/\/thepurbottar.in\/wp-content\/uploads\/2024\/02\/Glenmark.jpg","datePublished":"2024-02-03T08:28:07+00:00","dateModified":"2024-02-03T08:28:09+00:00","description":"Pfizer and Glenmark Pharmaceuticals Ltd. have partnered to launch abrocitinib, a unique oral advanced systemic treatment for moderate-to-severe atopic","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/thepurbottar.in\/glenmark-and-pfizer-partners-to-launch-abrocitinib-in-india\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepurbottar.in\/glenmark-and-pfizer-partners-to-launch-abrocitinib-in-india\/#primaryimage","url":"https:\/\/thepurbottar.in\/wp-content\/uploads\/2024\/02\/Glenmark.jpg","contentUrl":"https:\/\/thepurbottar.in\/wp-content\/uploads\/2024\/02\/Glenmark.jpg","width":1200,"height":776},{"@type":"WebSite","@id":"https:\/\/thepurbottar.in\/#website","url":"https:\/\/thepurbottar.in\/","name":"The Purbottar","description":"English News Paper","publisher":{"@id":"https:\/\/thepurbottar.in\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/thepurbottar.in\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/thepurbottar.in\/#organization","name":"The Purbottar","url":"https:\/\/thepurbottar.in\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepurbottar.in\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/thepurbottar.in\/wp-content\/uploads\/2023\/08\/purbottar-english-logo-544px.png?fit=544%2C180&ssl=1","contentUrl":"https:\/\/i0.wp.com\/thepurbottar.in\/wp-content\/uploads\/2023\/08\/purbottar-english-logo-544px.png?fit=544%2C180&ssl=1","width":544,"height":180,"caption":"The Purbottar"},"image":{"@id":"https:\/\/thepurbottar.in\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/purbottarnewsportal\/"]},{"@type":"Person","@id":"https:\/\/thepurbottar.in\/#\/schema\/person\/e6e81f9f5be6eff095fcc2a50437bfc6","name":"Business Bureau","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepurbottar.in\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/a3c076ea9e207c179b27b41ba41c073f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a3c076ea9e207c179b27b41ba41c073f?s=96&d=mm&r=g","caption":"Business Bureau"}}]}},"_links":{"self":[{"href":"https:\/\/thepurbottar.in\/wp-json\/wp\/v2\/posts\/46951","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thepurbottar.in\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thepurbottar.in\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thepurbottar.in\/wp-json\/wp\/v2\/users\/22"}],"replies":[{"embeddable":true,"href":"https:\/\/thepurbottar.in\/wp-json\/wp\/v2\/comments?post=46951"}],"version-history":[{"count":1,"href":"https:\/\/thepurbottar.in\/wp-json\/wp\/v2\/posts\/46951\/revisions"}],"predecessor-version":[{"id":46953,"href":"https:\/\/thepurbottar.in\/wp-json\/wp\/v2\/posts\/46951\/revisions\/46953"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/thepurbottar.in\/wp-json\/wp\/v2\/media\/46952"}],"wp:attachment":[{"href":"https:\/\/thepurbottar.in\/wp-json\/wp\/v2\/media?parent=46951"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thepurbottar.in\/wp-json\/wp\/v2\/categories?post=46951"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thepurbottar.in\/wp-json\/wp\/v2\/tags?post=46951"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}